vancomycin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Cui, C; Hong, H; Hong, Y; Li, CS; Niu, GY; Qiao, CM; Quan, W; Shen, YQ; Shi, Y; Wu, J; Wu, YB; Zhao, LP; Zhao, WJ; Zhou, Y | 1 |
1 other study(ies) available for vancomycin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Disease Models, Animal; Dopamine; Inflammation; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neuroprotection; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vancomycin | 2023 |